A team of researchers have discovered the interaction between an Ebola virus protein and a protein in human cells that may be an important key to unlocking the pathway of replication of the killer disease in human hosts. Scientists at Texas Biomedical Research Institute were part of a nationwide collaborative with scientists at Gladstone Institutes, UC San Francisco and Georgia State University for a study recently published in the journal Cell.
Friedrich Simmel und Aurore Dupin, researchers at the Technical University of Munich (TUM), have for the first time created artificial cell assemblies that can communicate with each other. The cells, separated by fatty membranes, exchange small chemical signaling molecules to trigger more complex reactions, such as the production of RNA and other proteins. This work was recently published in nature chemistry.
A new study conducted at Rush University Medical Center has found that keeping active in older age helps to maintain memory and thinking skills and reduces the risk of dementia . This was observed even in participants.
Immune cells engineered to attack childhood cancers were able to eradicate different types of pediatric tumors in mice, according to a new study from the Stanford University School of Medicine. The study, which will be published online Jan. 17 in Clinical Cancer Research, provides evidence that these engineered cells can target many types of pediatric solid tumors, including brain tumors.
The US Food and Drug Administration (FDA) has approved the first generic version of the anti-seizure medication Sabril. Generic vigabatrin (500-mg tablets), made by Teva Pharmaceuticals USA.
Scientists have developed tiny elastic robots that can change shape depending on their surroundings. Modeled after bacteria and fully biocompatible, these robots optimize their movements so as to get to hard-to-reach areas of the human body. They stand to revolutionize targeted drug delivery. One day we may be able to ingest tiny robots that deliver drugs directly to diseased tissue, thanks to research being carried out at EPFL and ETH Zurich.
A growing number of nurse practitioners are providing primary care in low-income areas and rural areas where there is a supply of studies led by the University of Rochester School of Nursing.
Poo transplant or "Faecal microbiota transplantation" (FMT) can successfully treat patients with ulcerative colitis, new research from the University of Adelaide shows. Researchers found a short duration of low intensity FMT using anaerobically.